BioCentury
ARTICLE | Clinical News

AccuSite gel consisting of 5-fluorouracil and epinephrine in bovine collagen: Began a Phase III open-label trial in 400 patients in the U.S., Europe, Australia

April 10, 1995 7:00 AM UTC

Matrix Pharmaceutical Inc. (MATX), Menlo Park, Calif. Product: AccuSite gel consisting of 5-fluorouracil and epinephrine in bovine collagen Indication: Basal cell skin cancer Status: Began a Phase II...